Arbutus Biopharma Corporation ABUS
$ 3.49
1.31%
Quarterly report 2024-Q3
added 11-06-2024
Arbutus Biopharma Corporation Cash and Cash Equivalents 2011-2024 | ABUS
Annual Cash and Cash Equivalents Arbutus Biopharma Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
26.3 M | 30.8 M | 109 M | 52.3 M | 31.8 M | 36.9 M | 54.3 M | 23.4 M | 167 M | 72.2 M | 68.7 M | 47 M | 9.03 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
167 M | 9.03 M | 56.1 M |
Quarterly Cash and Cash Equivalents Arbutus Biopharma Corporation
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.8 M | 62.8 M | 43.1 M | 26.3 M | 17.5 M | 27.2 M | 40.6 M | 30.8 M | 24 M | 47.3 M | 81.3 M | 109 M | 77.9 M | 31 M | 79.4 M | 52.3 M | 52.3 M | 52.3 M | 52.3 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 54.3 M | 54.3 M | 54.3 M | 54.3 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 167 M | 167 M | 167 M | 167 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 68.7 M | 68.7 M | 68.7 M | 68.7 M | 47 M | - | - | - | 9.03 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
167 M | 9.03 M | 57.4 M |